Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.
about
CA 19-9 and CA 125 as potential predictors of disease recurrence in resectable lung adenocarcinoma.Minimizing inequality in access to precision medicine in breast cancer by real-time population-based molecular analysis in the SCAN-B initiative.A Next-Generation Sequencing Primer-How Does It Work and What Can It Do?
P2860
Clinical framework for next generation sequencing based analysis of treatment predictive mutations and multiplexed gene fusion detection in non-small cell lung cancer.
description
2017 nî lūn-bûn
@nan
2017 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի մարտին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
Clinical framework for next ge ...... in non-small cell lung cancer.
@ast
Clinical framework for next ge ...... in non-small cell lung cancer.
@en
type
label
Clinical framework for next ge ...... in non-small cell lung cancer.
@ast
Clinical framework for next ge ...... in non-small cell lung cancer.
@en
prefLabel
Clinical framework for next ge ...... in non-small cell lung cancer.
@ast
Clinical framework for next ge ...... in non-small cell lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Clinical framework for next ge ...... in non-small cell lung cancer.
@en
P2093
Anna Karlsson
Christel Reuterswärd
Frida Rosengren
Göran Jönsson
Hans Brunnström
Jaroslaw Kosieradzki
Johan Staaf
Kajsa Ericson Lindquist
Karin Annersten
Karolina Holm
P2860
P304
34796-34810
P356
10.18632/ONCOTARGET.16276
P407
P577
2017-03-16T00:00:00Z